About Us: Overview

Code Bio was founded on the belief that so much more can be done for people living with debilitating genetic diseases. 

Led by seasoned leaders with expertise in business, biotechnology and nanotechnology, we are advancing an internal pipeline focused on select rare disease programs and establishing partnerships to take forward strategic programs that hold promise for both rare and prevalent diseases.

For patients suffering from debilitating genetic diseases, Code Bio’s novel non-viral gene delivery platform offers new hope for meaningful gene therapy solutions, across numerous indications, that are titratable, have the potential to be re-dosable, and able to address diseases with mutations in large genes.